JP2024532780A5 - - Google Patents
Info
- Publication number
- JP2024532780A5 JP2024532780A5 JP2024508498A JP2024508498A JP2024532780A5 JP 2024532780 A5 JP2024532780 A5 JP 2024532780A5 JP 2024508498 A JP2024508498 A JP 2024508498A JP 2024508498 A JP2024508498 A JP 2024508498A JP 2024532780 A5 JP2024532780 A5 JP 2024532780A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridine
- methylmorpholine
- cancer
- group
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232983P | 2021-08-13 | 2021-08-13 | |
| US63/232,983 | 2021-08-13 | ||
| US202263317500P | 2022-03-07 | 2022-03-07 | |
| US63/317,500 | 2022-03-07 | ||
| PCT/US2022/074925 WO2023019259A1 (en) | 2021-08-13 | 2022-08-12 | Combination therapy of vps34 inhibitors and sting agonist for use in the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532780A JP2024532780A (ja) | 2024-09-10 |
| JP2024532780A5 true JP2024532780A5 (cg-RX-API-DMAC7.html) | 2025-08-18 |
Family
ID=83188606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508498A Pending JP2024532780A (ja) | 2021-08-13 | 2022-08-12 | Vps34阻害剤を使用した併用療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250127790A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4384180A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024532780A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022326573A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3228766A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202320797A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023019259A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102708177B1 (ko) | 2018-01-31 | 2024-09-23 | 데시페라 파마슈티칼스, 엘엘씨. | 위장관 기질 종양의 치료를 위한 병용 요법 |
| GB2630970A (en) * | 2023-06-15 | 2024-12-18 | Duke Street Bio Ltd | PARP1 inhibitor compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU24377B1 (es) * | 2013-05-18 | 2018-12-05 | Aduro Biotech Inc | Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting |
| WO2015108881A1 (en) * | 2014-01-14 | 2015-07-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| PT3416957T (pt) | 2016-02-19 | 2020-09-25 | Sprint Bioscience Ab | Compostos 6-heterociclil-4-morfolin-4-ilpiridin-2-ona úteis para o tratamento do cancro e da diabetes |
| IL302356A (en) * | 2017-08-23 | 2023-06-01 | Sprint Bioscience Ab | Pyridylpyridone compounds |
| PL3672948T3 (pl) * | 2017-08-23 | 2022-12-05 | Sprint Bioscience Ab | Związki pirydynoamino-pirydonu i pirymidynoamino-pirydonu |
| WO2020008046A1 (en) * | 2018-07-06 | 2020-01-09 | Sprint Bioscience Ab | Biomarker |
-
2022
- 2022-08-12 CA CA3228766A patent/CA3228766A1/en active Pending
- 2022-08-12 EP EP22764625.4A patent/EP4384180A1/en active Pending
- 2022-08-12 AU AU2022326573A patent/AU2022326573A1/en active Pending
- 2022-08-12 WO PCT/US2022/074925 patent/WO2023019259A1/en not_active Ceased
- 2022-08-12 US US18/683,078 patent/US20250127790A1/en active Pending
- 2022-08-12 JP JP2024508498A patent/JP2024532780A/ja active Pending
- 2022-08-12 TW TW111130481A patent/TW202320797A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025143253A (ja) | Brm標的化化合物および関連使用方法 | |
| US7838524B2 (en) | Substituted pyrazolyl urea derivatives useful in the treatment of cancer | |
| JP2021119196A5 (cg-RX-API-DMAC7.html) | ||
| RU2018123825A (ru) | Соединения и способы для модуляции киназ, и показания для этого | |
| JP2022531801A5 (cg-RX-API-DMAC7.html) | ||
| TW200534853A (en) | Synergistic methods and compositions for treating cancer | |
| RU2018131766A (ru) | 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета | |
| KR102359759B1 (ko) | 세린/트레오닌 키나제 저해제 | |
| JP2017505794A5 (cg-RX-API-DMAC7.html) | ||
| JP2012525395A5 (cg-RX-API-DMAC7.html) | ||
| EA013231B1 (ru) | Замещенные амидные производные в качестве ингибиторов протеинкиназы | |
| JP2014500308A (ja) | Vps34阻害剤としてのビヘテロアリール化合物 | |
| MX2008006979A (es) | Compuestos de urea utiles en el tratamiento contra el cancer. | |
| EA029473B1 (ru) | Применение ингибиторов pi3k для лечения острой и церебральной малярии | |
| JP2020531488A5 (cg-RX-API-DMAC7.html) | ||
| RU2018131775A (ru) | 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета | |
| JP7688042B2 (ja) | アミド化合物およびその使用 | |
| FI3672948T3 (fi) | Pyridiiniamiinipyridoni- ja pyrimidiiniamiinipyridoniyhdisteitä | |
| JP2019505595A5 (cg-RX-API-DMAC7.html) | ||
| US20210355104A1 (en) | Adenosine receptor binding compounds | |
| JP2020531486A5 (cg-RX-API-DMAC7.html) | ||
| TW202430171A (zh) | 雜芳基氨基化合物及其製備方法和應用 | |
| JP2020531487A5 (cg-RX-API-DMAC7.html) | ||
| JP2024532780A (ja) | Vps34阻害剤を使用した併用療法 | |
| HRP20211999T1 (hr) | Spojevi azaindolilpiridona i diazaindolilpiridona |